Achilles Therapeutics Plc (ACHL)

[jondoeuk]

European Society for Gene and Cell Therapy (ESGCT) Congress:

Abstract Title: Multicentre, prospective research protocol for development of a clonal neoantigen-reactive T cell therapy pipeline across multiple tumour types
Presentation Number: OR54
Session: 6c Manufacturing
Session Time: Friday, October 22, 2021: 9:00am–11:00am CEST (3:00am–5:00am ET)
Presenter: Michael Grant, MB, BCh, BAO, BSc, PGCert, FHEA, Associate Medical Director, Achilles Therapeutics

Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

Abstract Title: Sensitive quantification and tracking of the active components of a Clonal Neoantigen T cell (cNeT) therapy: From manufacture to peripheral circulation
Poster Number: 543
Poster Presenter: Samra Turajlic, MD, MBBS, MRCP, PhD, THETIS Chief Investigator, Royal Marsden, London, UK

Abstract Title: The Achilles VELOS™ Process 2 boosts the dose of highly functional clonal neoantigen-reactive T cells for precision personalized cell therapies
Poster Number: 193
Poster Presenter: Joseph Robinson, PhD, Senior Scientist